The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

N.V. Fedorova

NII skoroĭ pomoshchi im. N.V. Sklifosovskogo, Moskva

F.K. Tekaeva

M.É. Bel'gusheva

Kafedra nevrologii Rossiĭskoĭ meditsinskoĭ akademii poslediplomnogo obrazovaniia

The role of the MAO-B inhibitor razagiline in the treatment of Parkinson's disease


N.V. Fedorova, F.K. Tekaeva, M.É. Bel'gusheva

More about the authors

Views: 3891

Downloaded: 57

To cite this article:

Fedorova NV, Tekaeva FK, Bel'gusheva MÉ. The role of the MAO-B inhibitor razagiline in the treatment of Parkinson's disease. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2011;111(7):30‑36. (In Russ.)

Email Confirmation

An email was sent to with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.